New Zealand markets close in 5 hours 49 minutes

Arcimoto, Inc. (FUV)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
0.4354-0.0206 (-4.52%)
At close: 04:00PM EDT
0.4600 +0.02 (+5.65%)
After hours: 06:58PM EDT
Full screen
Loading interactive chart…
  • GlobeNewswire

    Arcimoto to Present at the Sequire Investor Summit in Puerto Rico

    Eugene, OR, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Arcimoto is proud to announce that it will be presenting at the upcoming Sequire Investor Summit 2024. This highly anticipated event, scheduled for January 23-25, 2024, at Condado Vanderbilt Hotel in San Juan, Puerto Rico, promises to offer an array of exciting opportunities for funds, companies, and investors. Puerto Rico is home to many family offices, funds and wealthy investors due to its favorable tax benefits. It is one of the only places in th

  • GlobeNewswire

    Arcimoto, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

    EUGENE, Oregon , Nov. 28, 2023 (GLOBE NEWSWIRE) -- Arcimoto, Inc.® (NASDAQ: FUV), today announced that on November 22, 2023, it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its quarterly report on Form 10-Q for the period ended September 30, 2023 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the Securities

  • GlobeNewswire

    DMK Pharmaceuticals Restructures Executive Team to Support Next Phase of Growth

    Seth Cohen is appointed Chief Financial Officer, bringing over thirty years of financial industry experience to DMK, and seasoned corporate lawyer John Dorbin assumes role of General Counsel Corporate Secretary Appointments strengthen leadership team and provide financial and corporate expertise as the organization focuses on improving DMK’s existing commercial product portfolio and reducing opioid related deaths SAN DIEGO, Oct. 19, 2023 (GLOBE NEWSWIRE) -- DMK Pharmaceuticals Corporation (NASDA